Health Canada
- Status: approved
🇨🇦 latanoprost 0.005% ophthalmic solution in Canada
latanoprost 0.005% ophthalmic solution (latanoprost 0.005% ophthalmic solution) regulatory status in Canada.
Marketing authorisation
latanoprost 0.005% ophthalmic solution in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is latanoprost 0.005% ophthalmic solution approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for latanoprost 0.005% ophthalmic solution in Canada?
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.